IL-16 production is a mechanism of resistance to BTK inhibitors and R-CHOP in lymphomas.

Arribas AJ, Cannas E, Sartori G, Guidetti F, Cascione L, Napoli S, Forestieri G, Fuzio F, Pesenti E, Tarantelli C, Spriano F, Zucchetto A, Rossi FM, Bruscaggin A, Rinaldi A, Castro de Moura M, Jovic S, Raimondi A, Pittau RB, Terzi di Bergamo L, Ye X, Stathis A, Ben-David Y, Pan-Hammarström Q, Simonetta F, Stussi G, Zucca E, Gattei V, Brown JR, Esteller M, Rossi D, Bertoni F

Open source

DOI: 10.1182/blood.2025029956
Published: 2026 Sep 3
Container: Blood
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1182/blood.2025029956,
  title = {IL-16 production is a mechanism of resistance to BTK inhibitors and R-CHOP in lymphomas.},
  author = {Arribas AJ and Cannas E and Sartori G and Guidetti F and Cascione L and Napoli S and Forestieri G and Fuzio F and Pesenti E and Tarantelli C and Spriano F and Zucchetto A and Rossi FM and Bruscaggin A and Rinaldi A and Castro de Moura M and Jovic S and Raimondi A and Pittau RB and Terzi di Bergamo L and Ye X and Stathis A and Ben-David Y and Pan-Hammarström Q and Simonetta F and Stussi G and Zucca E and Gattei V and Brown JR and Esteller M and Rossi D and Bertoni F},
  year = {2026},
  journal = {Blood},
  doi = {10.1182/blood.2025029956},
  url = {https://doi.org/10.1182/blood.2025029956}
}

RIS

TY  - JOUR
TI  - IL-16 production is a mechanism of resistance to BTK inhibitors and R-CHOP in lymphomas.
AU  - Arribas AJ
AU  - Cannas E
AU  - Sartori G
AU  - Guidetti F
AU  - Cascione L
AU  - Napoli S
AU  - Forestieri G
AU  - Fuzio F
AU  - Pesenti E
AU  - Tarantelli C
AU  - Spriano F
AU  - Zucchetto A
AU  - Rossi FM
AU  - Bruscaggin A
AU  - Rinaldi A
AU  - Castro de Moura M
AU  - Jovic S
AU  - Raimondi A
AU  - Pittau RB
AU  - Terzi di Bergamo L
AU  - Ye X
AU  - Stathis A
AU  - Ben-David Y
AU  - Pan-Hammarström Q
AU  - Simonetta F
AU  - Stussi G
AU  - Zucca E
AU  - Gattei V
AU  - Brown JR
AU  - Esteller M
AU  - Rossi D
AU  - Bertoni F
PY  - 2026
JO  - Blood
DO  - 10.1182/blood.2025029956
UR  - https://doi.org/10.1182/blood.2025029956
ER  -

APA

AJ, A., E, C., G, S., F, G., L, C., S, N., G, F., F, F., E, P., C, T., F, S., A, Z., FM, R., A, B., A, R., M, C. D. M., S, J., A, R., RB, P., L, T. D. B., X, Y., A, S., Y, B., Q, P., F, S., G, S., E, Z., V, G., JR, B., M, E., D, R., & F, B. (2026). IL-16 production is a mechanism of resistance to BTK inhibitors and R-CHOP in lymphomas.. Blood. https://doi.org/10.1182/blood.2025029956

Source records

pubmed · retrieved 2026-09-25T21:09:11.819Z